Purple Biotech Ltd. (PPBT)
NASDAQ: PPBT
· Real-Time Price · USD
2.43
0.12 (5.19%)
At close: Aug 15, 2025, 3:59 PM
2.28
-6.17%
After-hours: Aug 15, 2025, 04:48 PM EDT
Purple Biotech Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -456K | -415K | -668K | -2.42M | -3.78M | -4.86M | -5.05M | -5.16M | -4.9M | -6.04M | -4.85M | -3.55M | -7.32M | -4.75M | -2.86M | -3.78M | -6.43M |
Depreciation & Amortization | 45K | 40K | 49K | 49K | 48K | 48K | 50K | 53K | 46K | 50K | 48K | 52K | 51K | 61K | 63K | 61K | 46K |
Stock-Based Compensation | 93K | -34K | 132K | 218K | 266K | 181K | 449K | 493K | 752K | 839K | 707K | 557K | 309K | 305K | 392K | 675K | 710K |
Other Working Capital | -118K | -556K | -205K | -611K | -884 | 137K | 549K | 244K | -1.99M | 2.23M | -918K | -457K | 2.73M | 1.1M | -182K | -2.86M | 2.75M |
Other Non-Cash Items | -950K | -601K | -1.47M | -773K | -685K | -1.41M | -692K | 25K | -219K | -558K | -232K | -38K | -15K | -197K | -211K | 179K | -253K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -210K | -164K | 155K | -155K |
Change in Working Capital | -710K | -1M | -1.34M | -1.05M | -930K | 1.06M | 1.59M | -634K | -1.74M | 1.5M | 706K | -720K | 1.77M | 830K | -323K | -2.21M | 2.45M |
Operating Cash Flow | -1.98M | -2.01M | -3.29M | -3.98M | -5.08M | -4.98M | -3.66M | -5.22M | -6.06M | -4.21M | -3.62M | -3.7M | -5.2M | -3.75M | -2.94M | -5.08M | -3.48M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | 1K | -1K | -3K | n/a | -5K | -6K | -217K | n/a | -6K | -82K | -27K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | n/a | 1.95M | -1.95M | n/a | n/a |
Sales Maturities Of Investments | 221K | n/a | -3K | 5K | 187K | -6K | 878K | 3K | 15.8M | 8M | n/a | -3.5M | 17.8M | 3.05M | 3.35M | 5.47M | 1.3M |
Other Investing Acitivies | 36K | 38K | 75K | 82K | 312.00 | 80K | 127K | 196K | 352K | 8K | 181K | -2.47M | 133K | 62K | 182K | 75K | 40K |
Investing Cash Flow | 257K | 38K | 72K | 87K | 312K | 74K | 1.01M | 198K | 12.6M | 8M | 177K | -5.98M | 17.72M | 5.06M | 1.57M | 5.46M | 1.31M |
Debt Repayment | -53K | -48K | -44K | -46K | -45K | -42K | -42K | -42K | -42K | -41K | -41K | -41K | -42K | -41K | -39K | -37K | -36K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -65K | -380K | 1.67M | -85K | -61K | 4.28M | -64K | -77K | -89K | -56K | -49K | -88K | -26K | -44K | -18K | -18K | 1.18M |
Financial Cash Flow | 103K | 3.94M | 2.13M | 433K | 268K | 4.25M | 572K | 367K | 264K | 89K | 569K | 294K | 162K | 479K | -57K | -55K | 1.15M |
Net Cash Flow | -1.63M | 1.96M | -1.09M | -3.46M | -4.5M | -615K | -2.1M | -4.68M | 6.85M | 3.96M | -2.93M | -9.53M | 12.65M | 1.77M | -1.42M | 345K | -1.05M |
Free Cash Flow | -1.98M | -2.01M | -3.29M | -3.98M | -5.08M | -4.98M | -3.65M | -5.22M | -6.07M | -4.21M | -3.63M | -3.71M | -5.42M | -3.75M | -2.95M | -5.16M | -3.5M |